Subsequently, the multivariate analysis, focusing on these previously identified significant factors, confirmed T stage, GS, LRP6, LRRK2, PIK3CA, and APOBEC3B deletion as significant predictors of metastatic prostate cancer. This evidence concerns the gene LRRK2 and metastatic prostate carcinoma.